OneMedNet (NASDAQ:ONMD) CFO Robert Lawrence Golden Sells 3,000 Shares of Company Stock

OneMedNet Corporation (NASDAQ:ONMD) CFO Robert Lawrence Golden sold 3,000 shares of the firm’s stock in a transaction that occurred on Tuesday, September 15th. The shares were sold at an average price of $6.30, for a total transaction of $18,900.00. Following the completion of the sale, the chief financial officer owned 94,291 shares of the company’s stock, valued at approximately $594,033.30. This trade represents a 3.08% decrease in their ownership of the stock. The sale was disclosed in a filing with the Securities & Exchange Commission, which is available through this hyperlink. The sale was made to cover tax withholding obligations related to the vesting of equity awards.

Robert Lawrence Golden also recently made the following trade(s):

• On Monday, September 21st, Robert Lawrence Golden sold 3,000 shares of OneMedNet stock. The stock was sold at an average price of $6.63, for a total value of $19,890.00.

OneMedNet Trading Down 10.8%

Shares of ONMD opened at $4.30 on Friday. OneMedNet Corporation has a 12 month low of $4.30 and a 12 month high of $42.20. The stock has a fifty day moving average price of $6.24 and a 200-day moving average price of $7.32. The firm has a market cap of $25.50 million, a PE ratio of -2.69 and a beta of 1.14.

Wall Street Analysts Forecast Growth

Separately, Weiss Ratings upgraded OneMedNet from a “sell (e+)” rating to a “sell (d-)” rating in a research note on Monday, August 24th. One equities research analyst has rated the stock with a Sell rating. According to MarketBeat.com, the stock currently has a consensus rating of “Sell”.

OneMedNet Company Profile

OneMedNet Corporation is a healthcare technology company that develops infrastructure for accessing, managing and analyzing medical data. Its platform is designed to help healthcare providers, researchers, life sciences companies and other authorized users work with clinical and medical-imaging information while keeping the underlying data within the organization that controls it.

The company’s technology uses a federated data model, allowing participating institutions to collaborate on data analysis without routinely transferring sensitive patient information to a centralized repository.